XTLB
NASDAQ
$2.29
X.T.L. Biopharmaceuticals Ltd (XTLB)
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company is headquartered in Ramat Gan, Israel.
Sector:
Healthcare
Industry:
Biotechnology
Target: $30 (+1210.04%)
Market Cap
$7.34M
Beta (5Y)
0.45
Price Chart
Valuation
Market Cap$7.34M
P/S7.58
P/B1.65
Profitability
Total Revenue (TTM)$968K
Gross Profit (TTM)-$2.25M
EBITDA-$1.97M
Operating Margin-854%
EPS-$0.90
Growth & Risk
Beta (5Y)0.45
Sharpe Ratio0.06